Dong Jie, Wang Dawei, Ma Zhenshen, Deng Guodong, Wang Lanhua, Zhang Jiandong
Department of Radiology, Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong 250014, P.R. China.
Department of Radiation Oncology, Qianfoshan Hospital Affiliated to Shandong University, Jinan, Shandong 250014, P.R. China.
Exp Ther Med. 2017 Mar;13(3):1069-1073. doi: 10.3892/etm.2017.4060. Epub 2017 Jan 18.
The aim of the study was evaluate the 3.0 T magnetic resonance (MR) perfusion imaging scanning time window following contrast injection for differentiating benign and malignant breast lesions and to determine the optimum scanning time window for increased scanner usage efficiency and reduced diagnostic adverse risk factors. A total of 52 women with breast abnormalities were selected for conventional MR imaging and T1 dynamic-enhanced imaging. Quantitative parameters [volume transfer constant (K), rate constant (K) and extravascular extracellular volume fraction (V)] were calculated at phases 10, 20, 30, 40 and 50, which represented time windows at 5, 10, 15, 20 and 25 min, respectively, following injection of contrast agent. The association of the parameters at different phases with benign and malignant tumor diagnosis was analyzed. MR perfusion imaging was verified as an effective modality in the diagnosis of breast malignancies and the best scanning time window was identified: i) Values of K and K at all phases were statistically significant in differentiating benign and malignant tumors (P<0.05), while the value of V had statistical significance only at stage 10, but not at any other stages (P>0.05); ii) values of V in benign tumors increased with phase number, but achieved no obvious changes at different phases in malignant tumors; iii) the optimum scanning time window of breast perfusion imaging with 3.0 T MR was between phases 10 and 30 (i.e., between 5 and 15 min after contrast agent injection). The variation trend of V values at different phases may serve as a diagnostic reference for differentiating benign and malignant breast abnormalities. The most efficient scanning time window was indicated to be 5 min after contrast injection, based on the observation that the V value only had statistical significance in diagnosis at stage 10. However, the optimal scanning time window is from 5 to 15 min following the injection of contrast agent, since that the variation trend of V is able to serve as a diagnostic reference.
本研究的目的是评估注射造影剂后 3.0 T 磁共振(MR)灌注成像的扫描时间窗,以鉴别乳腺良恶性病变,并确定最佳扫描时间窗,以提高扫描仪使用效率并降低诊断不良风险因素。共选取 52 例有乳腺异常的女性进行常规 MR 成像和 T1 动态增强成像。在第 10、20、30、40 和 50 期计算定量参数[容积转运常数(K)、速率常数(K)和血管外细胞外容积分数(V)],这些分别代表注射造影剂后 5、10、15、20 和 25 分钟的时间窗。分析不同期参数与良恶性肿瘤诊断的相关性。MR 灌注成像被证实是诊断乳腺恶性肿瘤的有效方法,并确定了最佳扫描时间窗:i)各期 K 和 K 值在鉴别良恶性肿瘤方面具有统计学意义(P<0.05),而 V 值仅在第 10 期具有统计学意义,在其他任何期均无统计学意义(P>0.05);ii)良性肿瘤中 V 值随期数增加,而恶性肿瘤在不同期无明显变化;iii)3.0 T MR 乳腺灌注成像的最佳扫描时间窗在第 10 期和第 30 期之间(即注射造影剂后 5 至 15 分钟)。不同期 V 值的变化趋势可作为鉴别乳腺良恶性异常的诊断参考。基于 V 值仅在第 10 期诊断中有统计学意义的观察结果,最有效的扫描时间窗显示为注射造影剂后 5 分钟。然而,最佳扫描时间窗是注射造影剂后 5 至 15 分钟,因为 V 的变化趋势能够作为诊断参考。